Main > HEMATOLOGY > Anemia > Iron-Deficiency Anemia > Treatment > Erythropoietin>Protein > Co.: IL. M. (GM DMO Implant) > Patent>Abstract

---

The present invention is directed to long-lasting therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes a therapeutic polypeptide, such as erythropoietin or interferon alpha


Patent>Abstract's products
This section has no products